- Previous Close
45.00 - Open
43.70 - Bid 42.85 x --
- Ask 44.00 x --
- Day's Range
42.85 - 44.00 - 52 Week Range
38.20 - 63.00 - Volume
22,411 - Avg. Volume
23,702 - Market Cap (intraday)
1.289B - Beta (5Y Monthly) --
- PE Ratio (TTM)
49.25 - EPS (TTM)
0.87 - Earnings Date --
- Forward Dividend & Yield 1.00 (1.87%)
- Ex-Dividend Date Aug 24, 2023
- 1y Target Est
--
BiOptic Inc., a biotechnology instrumentation company, develops scientific products for research and clinical applications. It offers instruments, such as bio-fragment analyzers and PCR thermocyclers; consumables, including DNA, RNA, and protein cartridges, as well as quantification kits; premix and polymerase PCR reagents; and veterinary, human, and food related testing kits. BiOptic Inc.was founded in 1993 and is headquartered in New Taipei City, Taiwan.
www.bioptic.com.twRecent News: 6850.TWO
View MorePerformance Overview: 6850.TWO
Trailing total returns as of 4/21/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 6850.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 6850.TWO
View MoreValuation Measures
Market Cap
1.34B
Enterprise Value
1.36B
Trailing P/E
51.66
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.66
Price/Book (mrq)
3.10
Enterprise Value/Revenue
6.71
Enterprise Value/EBITDA
25.55
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
0.87
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--